Avik Pharmaceutical Limited

Avik Pharmaceutical Limited - pharma in Mumbai, Maharashtra, India. FY 2026 financials and compliance.
CIN U99999MH1979PLC021711 Incorporated 25 September 1979 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Public Limited Company pharma
Data last updated
Revenue · FY 2025
₹103.38 Cr
▲ 29.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹12 Cr
Registered with MCA
Paid-up capital
₹10.88 Cr
Issued & subscribed
Open charges
₹25.43 Cr
Satisfied ₹19.02 Cr
Company age
47 yrs
Est. 1979
Employees · EPFO
174
Latest available

About Avik Pharmaceutical Limited

Data last updated: 05 January 2026

Avik Pharmaceutical Limited is a public limited company based in Mumbai, Maharashtra, India. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 25 September 1979, the company has been in operation for over 47 years.

Registered with ROC Mumbai under CIN U99999MH1979PLC021711.

Capital: an authorised share capital of ₹12 Cr and a paid-up capital of ₹10.88 Cr. Formerly known as Avik Pharmaceuticals Limited and Avik Pharmaceuticals Private Limited. It is led by directors including Jeevan Lal Nagori and Anant Rajendralal Thakore.

Last AGM: 11 September 2025. Financial statements filed for year ended 31 March 2025. Office: Mumbai, Maharashtra.

As per the financials filed for FY 2025, the company reported a revenue of ₹103.38 Cr, a growth of 29% compared to the previous year.

The company has a workforce of approximately 174 employees as per the latest available data.

The company is associated with 1 brand - Avik Pharmaceuticals. As per MCA filings, the company has open charges of ₹25.43 Cr and satisfied charges of ₹19.02 Cr on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website avikpharma.com.

Company Details of Avik Pharmaceutical Limited
CIN U99999MH1979PLC021711
Registration Number 021711
Incorporation Date 25 September 1979
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 11 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
  • Social Media
  • Registered Address
    Arvind Chambers Gauri Compound 188 Kurla Road Ground Floor Western Express Highway An, Dheri (E), Mumbai, Maharashtra, India – 400069
  • Industry
    Pharma, API Manufacturers
Company report
Avik Pharmaceutical Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Avik Pharmaceutical Limited report

Financials, compliance, directors, charges, ownership and filings for Avik Pharmaceutical Limited in one report.

10-year financials Directors & ownership Charges & compliance

Name History of Avik Pharmaceutical Limited

Avik Pharmaceutical Limited has undergone 2 name changes throughout its history. The company was previously known as Avik Pharmaceuticals Limited, and Avik Pharmaceuticals Private Limited. The current legal name is Avik Pharmaceutical Limited, reflecting the company's evolution and rebranding over time.

Company Name Status
Avik Pharmaceutical Limited Current
Avik Pharmaceuticals Limited Previous
Avik Pharmaceuticals Private Limited Previous

CIN History of Avik Pharmaceutical Limited

Avik Pharmaceutical Limited has one previous CIN (Corporate Identification Number): U99999MH1979PTC021711. The current CIN is U99999MH1979PLC021711, which is the unique identifier assigned by the Registrar of Companies.

CIN Status
U99999MH1979PLC021711 Current
U99999MH1979PTC021711 Previous

Associated Brands with Avik Pharmaceutical Limited

Avik Pharmaceutical Limited operates one associated brand: Avik Pharmaceuticals. These brands represent Avik Pharmaceutical Limited's diversified market presence and brand portfolio.

Brand Description Website
Manufactures corticosteroids and steroid APIs for pharmaceutical industry. avikpharma.com

Competitors & Alternatives of Avik Pharmaceutical Limited

Brands and companies operating in the same space as Avik Pharmaceutical Limited include Laurus Labs, Symbiotec, Beijing Biostar Technologies and 6 more.

Competitor Description Location Founded
Laurus Labs Laurus Labs Pharmaceutical and biotechnology company Hyderabad, India, India 2005
Symbiotec Symbiotec Non-sterile steroid hormone-based APIs and intermediates are manufactured. Indore, India, India 2002
Beijing Biostar Technologies Beijing Biostar Technologies APIs, intermediates, and biochemical reagents are developed and manufactured. Beijing, China, China 2002
Sterling Pharma Solutions Sterling Pharma Solutions Contract development, manufacturing, and analytical services for APIs are offered. Dudley, United Kingdom, United Kingdom 2016
Provepharm Life Solutions Provepharm Life Solutions APIs and drug products are developed and valorized in pharmaceuticals. Marseille, France, France 1998
Hikal Hikal APIs and intermediates are produced via custom synthesis and research. Mumbai, India, India 1988
Snapdragon Chemistry Snapdragon Chemistry Drug discovery and development service provider Cambridge, United States, United States 2014
SeQuent SeQuent APIs are developed and manufactured for therapeutic areas. Bengaluru, India, India 2002
Jubilant Pharma Jubilant Pharma Pharmaceuticals, APIs, and radiopharmaceuticals are manufactured by the company. Noida, India, India 1978

Business Activity of Avik Pharmaceutical Limited

Avik Pharmaceutical Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
C Manufacturing C6 Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products Locked
Premium access

Business activity turnover details for Avik Pharmaceutical Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Avik Pharmaceutical Limited

Avik Pharmaceutical Limited is audited by AGRAWAL & MANGAL for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
AGRAWAL & MANGAL Locked Locked Locked
Premium access

Complete auditor history for Avik Pharmaceutical Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors and KMP of Avik Pharmaceutical Limited

Avik Pharmaceutical Limited currently reports 5 directors and 1 key managerial person. 9 former directors have served the organization.

Current Directors and KMP
Name Designation Appointment Date Tenure Status
Jeevan Lal Nagori Director 18 Nov 2013 12 Years 7 Months Current
Anant Rajendralal Thakore Managing Director 25 Sep 1979 46 Years 9 Months Current
Neha Anant Thakore Whole-Time Director 04 Jan 2022 4 Years 6 Months Current
Rajeshree Maruti Chougule Company Secretary 19 Dec 2024 1 Years 6 Months Current
Raj Kamal Prasad Verma Director 16 Sep 2024 1 Years 9 Months Current
Sushil Kumar Kumra Director 16 Sep 2024 1 Years 9 Months Current

Financials of Avik Pharmaceutical Limited FY 2025 filings available

Avik Pharmaceutical Limited reported revenue of ₹103.38 Cr (up 29.00% YoY) for FY 2025.

Revenue · FY 2025
₹103.38 Cr ▲ 29.00%
Premium access

Ten-year financial statements for Avik Pharmaceutical Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Avik Pharmaceutical Limited

Premium access

Shareholding and ownership data for Avik Pharmaceutical Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Group Structure of Avik Pharmaceutical Limited

Avik Pharmaceutical Limited has 1 joint venture. This group structure data is as of FY 2023. The corporate group structure reflects Avik Pharmaceutical Limited's business expansion strategy and organizational complexity.

1
Joint ventures

Charges & Borrowings of Avik Pharmaceutical Limited

Open charges
₹25.43 Cr
Satisfied charges
₹19.02 Cr
Breakdown by lending institutions
Yes Bank Limited₹25.43 Cr
Latest charge details
DateLenderAmountStatus
04 Jun 2025 Yes Bank Limited ₹5 Cr Open
20 May 2015 Yes Bank Limited ₹20.43 Cr Open
21 Apr 1999 Indian Bank ₹12.39 Cr Satisfied
04 Mar 1998 Central Bank of India ₹1.3 Cr Satisfied
28 Apr 1994 Indian Bank ₹25 Lakh Satisfied

Total charge records: 23 View all charges

Employees and EPFO Compliance at Avik Pharmaceutical Limited

Avik Pharmaceutical Limited has a workforce of 174 employees as of Mar 30, 2024.

Employee count
174
Active EPFO establishments
1
Employee growth
-4.4%
Premium access

Employee and EPFO history for Avik Pharmaceutical Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Avik Pharmaceutical Limited

Premium access

GST registrations and filing compliance for Avik Pharmaceutical Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Avik Pharmaceutical Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Avik Pharmaceutical Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Avik Pharmaceutical Limited

Premium access

MSME payment history for Avik Pharmaceutical Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Avik Pharmaceutical Limited

Premium access

Corporate group structure for Avik Pharmaceutical Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Avik Pharmaceutical Limited

Premium access

MCA filings and documents for Avik Pharmaceutical Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Avik Pharmaceutical Limited

Directors
12 Oct 2025
Sarita Loriknath Yadav was appointed as a CFO on 12 Oct 2025 & has been associated with this company since 9 months 2 days.
Activity
11 Sep 2025
Avik Pharmaceutical Limited last Annual general meeting of members was held on 11 Sep 2025 as per latest MCA records.
Charges
04 Jun 2025
A charge with Yes Bank Limited amounted to Rs. 5.00 Cr with Charge ID 101111400 was registered on 04 Jun 2025.
Activity
31 Mar 2025
Avik Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Directors
19 Dec 2024
Rajeshree Maruti Chougule was appointed as a Company Secretary on 19 Dec 2024 & has been associated with this company since 1 year 6 months.
Directors
16 Sep 2024
Raj Kamal Prasad Verma was appointed as a Director on 16 Sep 2024 & has been associated with this company since 1 year 9 months.

Frequently Asked Questions about Avik Pharmaceutical Limited

Avik Pharmaceutical Limited is an active public limited company in the pharma sector based in Mumbai, Maharashtra, India. It was incorporated on 25 September 1979 (47+ years old) and is registered under CIN U99999MH1979PLC021711. The company has 174 employees.

Avik Pharmaceutical Limited reported revenue of ₹103.38 Cr for FY 2025 (up 29.00% YoY).

The current directors and KMP of Avik Pharmaceutical Limited are:

The primary industry of Avik Pharmaceutical Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.

Avik Pharmaceutical Limited can be reached at the registered office: Arvind Chambers Gauri Compound 188 Kurla Road Ground Floor Western Express Highway An, Dheri E, Mumbai, Maharashtra, India – 400069, or through the website avikpharma.com.

The authorised capital is ₹12 Cr, and the paid-up capital is ₹10.88 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available